Analgesics: Page 27

Politics prompt permanent end to U.S. Pentothal production
By Rob Goszkowski
Concerns about liability for Pentothal being used in prison executions and production issues have compelled Hospira -- the only U.S. manufacturer of the anesthetic -- to permanently discontinue production of the drug.
January 24, 2011
2011 01 25 11 23 22 743 I Vsedation2 70
Amgen to pay $1B for firm developing head/neck cancer drug
By DrBicuspid.com staff writers
Biotechnology giant Amgen has agreed to acquire BioVex Group, a privately held biotechnology company that is developing OncoVex, a novel oncolytic vaccine to treat head and neck cancer and melanoma.
January 23, 2011
FDA warns Dentsply about advertising violations
By Rob Goszkowski
In what is being characterized as "serious" violations, the U.S. Food and Drug Administration has issued a warning letter to Dentsply for misbranding its localized anesthetic Oraqix in a journal ad and professional mailers.
January 18, 2011
2009 07 28 13 33 39 581 Fda Logo 70
4th Merck osteonecrosis trial begins
By DrBicuspid.com staff writers
Merck will again "vigorously defend itself" against allegations that its Fosamax bisphosphonate drug caused dental and jaw-related problems in a jury trial that began January 18 in New Jersey.
January 17, 2011
FDA limits acetaminophen in combination products
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) is asking manufacturers of prescription combination products that contain acetaminophen to limit the amount of acetaminophen to no more than 325 milligrams in each tablet or capsule.
January 12, 2011
Ohio dentist in teen's death settled prior lawsuit
By DrBicuspid.com staff writers
Henry Mazorow, DDS, the 80-year-old Ohio dentist who performed oral surgery on a 13-year-old who died after he extracted two of her teeth, settled a wrongful death lawsuit regarding another patient more than a decade ago, according to a story in the Chronicle-Telegram.
January 9, 2011
Moxifloxacin beats clindamycin for some odontogenic infections
By Reuters Health
NEW YORK (Reuters Health) - Moxifloxacin was significantly more effective than clindamycin at controlling the pain of odontogenic/gingival inflammatory infiltrates, in a small phase II study by German researchers.
January 9, 2011
2009 07 13 09 44 04 276 Bottle Pills 70
Head/neck cancer drug shows promise in clinical trials
By DrBicuspid.com staff writers
CEL-SCI has begun a phase III clinical trial for Multikine, its flagship immunotherapy drug for head and neck cancer. The goal is to establish Multikine as a first-line standard of care therapy in treating newly diagnosed head and neck cancer patients.
January 5, 2011
Private equity firm acquires OraPharma
By Kathy Kincade
Water Street Healthcare Partners, a strategic private equity firm, has acquired OraPharma from Johnson & Johnson and plans to build it into a leading specialty pharmaceutical company focused on dental and oral healthcare.
January 4, 2011
2011 01 05 11 23 11 200 Hands Shaking Deal 70
Calif. dentist denied parole in fatal anesthesia case
By DrBicuspid.com staff writers
A Costa Mesa, CA, dentist convicted of killing three patients by giving them fatal doses of anesthesia has been denied parole, according to an article in the Daily Pilot.
December 29, 2010
Are AMSA nerve blocks more effective than IONBs?
By DrBicuspid.com staff writers
Is an anterior middle superior alveolar (AMSA) nerve block more effective than an infraorbital nerve block (IONB) in achieving pulpal anesthesia in the anterior maxilla? Researchers from Newcastle University recently conducted a small clinical trial to investigate.
December 26, 2010
Bad bacteria common on anesthesia providers' hands
By DrBicuspid.com staff writers
Contaminating bacteria are very commonly found on the hands of anesthesia providers, with high rates of transmission to the surgical field during operations, reports a study in the January issue of Anesthesia & Analgesia.
December 21, 2010
Previous Page
Page 27 of 43
Next Page